Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June, 2026.

LaAjENBU RKT Jenburkt Pharmaceuticals Limited UNICORN, 14th Floor, Dattaji Salvi Marg, Off Veera Desai Road, Andheri West, Mumbai 400 053. Phone: 022-67 603 603 Ref. No. JPL/CS/2337/2026 Date: 07" August, 2026. BSE Ltd. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001. Script Code : 524731 Sub. : Newspapers Publications of Standalone Unaudited Financial Results for the quarter ended on 30' June, 2026. Dear Sir, With reference to our letter No. JPL/CS/2336/2026 dated 06" August, 2026, kindly find enclosed, clippings of following two Newspapers dated 07" August, 2026, containing the Standalone Unaudited Financial Results of the Company for the quarter ended on 30" June, 2026. (1) The Free Press Journal, Mumbai (English) and (2) Navshakti, Mumbai (Marathi). Kindly acknowledge. Thanking you, Yours faithfully, Fox Jenburkt Pharmaceuticals Limited, s¥ Science hai toh Hope hai 3% Hope hai toh Health hai £% Health hai toh Happiness hai 3 > Email: info@jenburktcom www.jenburkt.com CIN No. L24230MH1985PLC036541 x www+/freepressjournalin Mumbai, Friday, August 7, 2026 | THE FREE PRESS JOURNAL | 21 JEN BURKT PHARMACEUTICALS LIMITED CIN: L24230MH1985PLC036541 [AWJENBURK | Registered Office: UNICORN, 14th Floor, Dattaji Salvi Marg, Off Veera Desai Road, Andheri (West), Mumbai-400 053 Delivering Excellence in Life Sciences 022 - 67603603 Website: www.jenburkt.com © E-mail: investor@jenburkt.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30" JUNE, 2026 The Board of Directors of the Company, at their meeting held on Thursday, 06" August, 2026 approved the unaudited standalone financial results of the Company forthe quarter ended on 30" June, 2026. The full format of the financial results of the Company, are available on the Stock Exchange website at www.bseindia.com and are also posted on the Company's website at https://jenburkt.com/investors/financial-results which can be accessed by scanning the Quick Response (QR) code. By order of the Board For JENBURKT PHARMACEUTICALS LIMITED (Ashish U. Bhuta) Place : Mumbai Chairman & Managing Director Date : 06”"August, 2026 (DIN: 00226479) NOTES: The above intimation is in accordance with Regulation 33 read with Regulation 47(1) of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. tad, WER© AsirNes ,209 8 vasske @ Waa ere avTateaicaca fates FIAT : U2 23 OUCH Be TTT 0 BRL YS ENBI IRK | Fariae r: ahe ere, Qva Ase, sare Greet art, ais fet Fars TE, at (afr), Hae-¥oo o4s, Delivering Excellence in Life Sciences 022 RohozRoz iom_ > aaaee : www. jenburkt.com @ 3-H : investor@jenburkt.com 30 Fa, 2026 Wah Baer Taarérarest sterarak tara attera fartta Trenaferraeco r TRS, of STE, 2026 Toft Sree are BEA Soe Gas HSM 30 GA, 2o2G Ue Guest fest art Haima afters stenaraftfara facta aren fad feasts ayet frac www.bseindia.com 34 tela Ueda qaarse aftr https://jenburkt.com/investors/financial-results 4a hati aaaSA cSIaS are. S fees Reqi-a (FqsR) His Sha HEA Tea Ada. foamrt : Was ; eae anit saaearreWhaTr a FeaTs : of SITES, 2026 (StarTAWA: 00224492) PER RCer hc macy|